ASCO: Adjuvant FOLFOX after neoadjuvant chemo-radiotherapy may significantly improve DFS in rectal can-cer

‘the first randomized study to show clinical benefits of FOLFOX in patients with rectal cancer after preoperative chemoradiotherapy and surgery’
‘the first randomized study to show clinical benefits of FOLFOX in patients with rectal cancer after preoperative chemoradiotherapy and surgery’